Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update

Publisher： Karger

E-ISSN： 1664-5553|6|1|1-12

ISSN： 2235-1795

Source： Liver Cancer, Vol.6, Iss.1, 2016-11, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immune Checkpoint Blockade in Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 4, Iss. 4, 2015-0 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Recent Trends in the Management of Hepatocellular Carcinoma with Special Emphasis on Treatment with Regorafenib and Immune Checkpoint Inhibitors

By  

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 714-730

Karger

Access to resources Recommend Favorite

Immune Responses in Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 150-154

Karger

Access to resources Recommend Favorite

Clinical Trials in Hepatocellular Carcinoma: An Update

By  

Liver Cancer, Vol. 2, Iss. 3-4, 2013-08 ,pp. : 345-364

Karger

Access to resources Recommend Favorite

Chronic Liver Diseases and Hepatocellular Carcinoma: An Update for 2013

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 405-407

Karger

Access to resources Recommend Favorite